Archer nears completion of first Midnight aircraft build

First Midnight electric vertical takeoff and landing (eVTOL) aircraft build. Photo Credit: Archer Aviation Archer Aviation Inc. (Santa Clara, Calif., U.S.) announced on March 9th that it is nearing completion of the final assembly of its first Midnight, the production aircraft it unveiled last November. All major aerostructures (i.e., wing, tail and fuselage, reported to be composite) have been built and mated together and the company reported it has also installed a significant portion of the wiring, electronics, actuators and other systems. Archer is currently targeting to begin flight testing of this aircraft in mid-2023. Archer has also now begun component manufacturing for its conforming Midnight aircraft, which will be flown with a pilot. Archer intends to build at least six of these conforming Midnight aircraft to be used as part of its “for credit” testing with the Federal Aviation Administration (FAA) in support of type certification. The company is targeting completion of its initial conforming Midnight aircraft in Q4 2023. In turn, that conforming aircraft would then begin piloted flight test operations in early 2024. These aircraft are set to be built at Archer’s San Jose, California, manufacturing facility and integrated test lab, located strategically just around the corner from its headquarters. “A lot goes on behind the scenes to advance the development of our aircraft as efficiently as we have. I couldn’t be more excited to share the news of Archer’s progress on Midnight,” Tom Muniz, Archer’s COO, says. “This latest milestone is further validation of our strategic approach of using known building blocks to enable realistic innovation significantly de-risking our path to certification and mass manufacturing. The team and I are looking forward to moving this aircraft into flight testing soon and continuing on our path to flying our conforming aircraft in early 2024.”
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.